Cannabis Bioscience International Holdings, Inc. (CBIH) Operating Expenses (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Operating Expenses across 5 years of filings, most recently posting $101419.0 for Q1 2026.

• In Q1 2026, Operating Expenses fell 18.71% year-over-year to $101419.0; the TTM figure through Feb 2026 stood at $496214.0 (down 19.26% YoY), while the FY2025 annual figure was $684281.0, down 0.74% from the prior year.
• Operating Expenses came in at $101419.0 for Q1 2026 at Cannabis Bioscience International Holdings, down from $138643.0 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $311998.0 in Q1 2023 to a low of $90841.0 in Q3 2025.
• Average Operating Expenses over 5 years is $182552.0, with a median of $154239.5 recorded in 2023.
• Year-over-year, Operating Expenses sank 68.68% in 2024 and soared 72.89% in 2025.
• Over 5 years, Operating Expenses stood at $259099.0 in 2022, then tumbled by 44.74% to $143168.0 in 2023, then slipped by 11.94% to $126072.0 in 2024, then rose by 9.97% to $138643.0 in 2025, then dropped by 26.85% to $101419.0 in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $101419.0 in Q1 2026, $138643.0 in Q4 2025, and $90841.0 in Q3 2025.